Unlike prescription GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro for type 2 diabetes, Zepbound for obesity)which is actually a dual GIP/GLP-1 receptor agonistthese probiotic formulations contain specific bacterial strains, most commonly Lactobacillus and Bifidobacterium species, that manufacturers claim may stimulate endogenous GLP-1 secretion from intestinal L-cells
The main effects of Treatment (F( 1, 47 ) = 72.550, p 2 = 0.607, p = 0.000), Diet (F( 1, 47 ) = 6.798, p 2 = 0.126, p = 0.012) and sex (F( 1, 47 ) = 5.451, p 2 = 0.104, p = 0.024), were also significant, there were no other significant main or interaction effects ( p 0.062)
Hormonal/Metabolic APIs
Nano Silver-Induced Toxicity and Associated Mechanisms